Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus topical ointment (0.1% Formulation B)

tacrolimus · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tacrolimus topical ointment (0.1% Formulation B), covering 2014-01-22 to 2014-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis [Phase 1]

See pricing